Nigerian-German Chemicals Plc

(NGC PLC)
CORPORATE PROFILE

Trust, Live, Enjoy

INTRODUCTION

NGC LEGACY
NGC is a Vibrant cm!an" #ha# is committed # im!r$ing !e!les%
li$es in a transparent an& socially responsible 'a"(
)*il&ing n i#s sli& m*l#ina#inal heri#age+ NGC,s cmmi#men# #
,-es# !rac#ice, in -*siness managemen# an& #he !*rs*i# .
man*.ac#*ring e/cellence has ena-le& i# # .rge s#ra#egic
rela#inshi!s 'i#h a n*m-er . -l*e chi! cm!anies # cm!lemen#
i#s lng s#an&ing #ra&i#in . man*.ac#*ring as 'ell as #ra&ing 0*ali#"
lcal an& in#erna#inal -ran&s(
NGC s#an&s *# as Nigeria,s .rems# in&igen*s en#er!rise in #he
!harmace*#ical an& chemical .iel&s+ !r$i&ing 'rl&-class
cm!anies 'i#h a $ehicle # !rm#e 1 &is#ri-*#e #heir !r&*c#s in #he
ms# challenging . en$irnmen#s(
Thr*gh i#s e/#ensi$e na#in-'i&e &is#ri-*#in ne#'r2+ NGC ser$es
a n*m-er . 2e" mar2e# sec#rs incl*&ing3
4 5eal#hcare
4 Cns*mer Pr&*c#s
4 Oil 1 Gas In&*s#r"

CORPORATE 6LOGAN 7 PAYOFF
TRUST
As a .rems# !r&*cer . !harmace*#ical an& #her li.e
enhancing !r&*c#s+ NGC is mre #han 8*s# a name( I# is an icn
. en&*ring #r*s# 'hich s#ems .rm i#s #ime #es#e& !e&igree an&
commitment # s#an&ar&(
LIVE
E$er" secn&9 e$er" min*#e9 e$er" h*r in$es#e& n
!r&*cing an" . #he NGC -ran&s+ is aime& a# ma2ing !e!le
li$e $i-ran# an& -e##er li$es(
ENJ!
A# NGC i#%s n# 8*s# a-*# li$ing+ i#%s a-*# en8"ing li.e ac#i$el"(
The ne' NGC is transparently cmmi##e& # cns#an#l"
im!r$ing i#s e/is#ing -ran&s as 'ell as &e$el!ing ne' Pr&*c#s
#ha# ma2e li.e mre en8"a-le(

:I6ION 1 ;I66ION 6TATE;ENT

:I6ION
<e 'an# # -*il& a .rems#+ !r.i#a-le an&
es#eeme& cr!ra#in #ha# ena-les !e!le
li$e mre ac#i$e an& .*l.illing li$es(

;I66ION 6TATE;ENT
<e are cmmi##e& # e/!an&ing mar2e#
share in #he !harmace*#ical+ .as# m$ing
cns*mer g&s an& il 1 gas sec#rs
'hile cn#in**sl" &i$ersi."ing in# ne'
-*siness areas(

:ALUE6
:i-ran#3
<e are a -l&+ !rac#i$e an& li$el" -ran& #ha# cnsis#en#l" s*!!r#
c*s#mers% 0*es# .r an ac#i$e an& heal#h" li.e( Thr*gh *r 'ell #raine&+
m#i$a#e& an& &e&ica#e& 'r2.rce 'e are al'a"s rea&" # e/!erimen# 1
&isc$er 'hile insis#ing n s#an&ar&s(
Cmmi##e&3
<e g #he e/#ra mile # 2n' #he nee&s . *r c*s#mers= cnsci*sl"
-*il&ing li.e-lng rela#inshi! 'i#h #hem -" crea#ing -ran&s #ha# &eli$er $al*e
a# e$er" s#age . li.e(
Trans!aren#3
<e are al'a"s !en in e$er"#hing 'e &( <e crea#e cmm*nica#in
channels #ha# gi$e #he c*s#mers an& #her s#a2ehl&ers mre access #
'ha# 'e & an& h' 'e & #hem( The c*s#mers 2n' *s 1 2n' #ha#
'ha#e$er cmes .rm *s cmes 'i#h a seal . s#an&ar& an& *n!arallele&
0*ali#"(
6ciall" res!nsi-le3
<e #a2e meas*res #ha# ens*re #ha# *r !era#inal !rcesses & n# ha$e
an" nega#i$e im!ac# n #he en$irnmen# an& #he !e!le(

O:ER:IE<

A .*ll" 'ne& Nigerian cm!an"

4 >*#e& n #he Nigerian 6#c2 E/change(
4 O$er ?@+@@@ sharehl&ers(

C*n#r" 'i&e &is#ri-*#in ne#'r2 'i#h $er ?+AB@ sales

!in#s

Em!l"ee s#reng#h . $er C@@

6#ra#egic alliances 'i#h -l*e chi! in#erna#inal cm!anies

incl*&ing Dhnsn 1 Dhnsn+ De"es+ E*nming
Pharmace*#ical Cr!ra#in+ 6l$a" Pharma+ Lin#n
Par2+ Nichls e# al

NGC 6TORY

NGC 6TORY
?FGH3
n "ecember #$, t%e company &as 'ormed under t%e name ()oec%st *roducts
Ni+eria Limited,
?FGC3
On Dan*ar" ?@+ #he cm!an" 'as regis#ere& as a !ri$a#e lia-ili#" cm!an" 'i#h an
a*#hriIe& share ca!i#al . #en #h*san& !*n&s (J?@+@@@) &i$i&e& in# #en #h*san&
(?@+@@@) r&inar" shares . J? each( On D*l" G+ #he a*#hriIe& share ca!i#al 'as
increase& # .i.#" #h*san& !*n&s (JB@+@@@) -" #he crea#in . an a&&i#inal .*r#"
#h*san& (C@+@@@) r&inar" shares . J? each(
On A*g*s# C+ #en #h*san& (?@+@@@) r&inar" shares . 'hich Far-'e2er2e 5echs#
AG hel& G@K an& ;a8r 1 Cm!an" C@K(
?FL?3
n ctober -, *V. plant at I/eja &as commissioned0
?FLA3 On Dan*ar" ?@+ #he a*#hriIe& share ca!i#al 'as increase& # .*r h*n&re&
#h*san& !*n&s (JC@@+@@@) -" #he crea#in . an a&&i#inal #hree h*n&re& an& .i.#"
#h*san& (HB@+@@@) r&inar" shares . J? each(
?FLH3 On A!ril ?H+ ;a8r 1 Cm!an" sl& #heir C@K sharehl&ing # Asham* 1 6ns
(5l&ings) L#&( On #he same &a" #he name . #he cm!an" 'as change& # MNigerian
5echs# Limi#e&N
?FLL+ ?FLO3 The a*#hriIe& share ca!i#al 1 !ai& *! ca!i#al 'ere increase& # #hree
millin Naira (NH+@@@+@@@) in A s#ages (n Dec G ?FLL 1 ;ar ?G ?FLO) -" #he crea#in
. a&&i#inal shares an& -" a !*-lic iss*e n Oc# AL+ ?FLO

NGC 6TORY 9 (cn#in*e&)
?FLF3
In .u+ust, Ni+erian )oec%st s%ares &ere 1uoted on t%e Ni+erian Stoc/
E2c%an+e 'or t%e 'irst time0 The 0*#a#in 'as H@ 2- !er share . B@
2- each(
?FO?3
n 3ay 45, t%e 'oundation o' t%e p%armaceutical 'actory at tta &as
laid
?FOA+ ?FOB+ ?FOO3
Nov -, #6$4 t%e p%armaceutical 'actory and t%e central &are%ouse at
tta &ere o''icially commissioned0
The a*#hriIe& share ca!i#al 'as increase& # .i.#een millin Naira
(N?B+@@@+@@@) in #' s#ages (n A*g AG+ ?FOA 1 D*l" B+ ?FOB) .rm #hree
millin 'hile #he !ai&-*! ca!i#al increase& # .*r#een millin Naira
(N?C+@@@+@@@) -" an h"-ri& ..ering in 6e!# ?FOA+ -n*s iss*e . ne
r&inar" share alrea&" hel& n D*l" ?B+ ?FOB an& -n*s shares . ne
r&inar" share .r e$er" #hree hel& n D*ne H@+ ?FOO(
?FOO3
n "ecember #$, t%e company celebrated its 47t% anniversary

NGC 6TORY 9 (cn#in*e&)
?FFA3
The cm!an" ..ere& .r s*-scri!#in &e-en#*re s#c2 . si/#" millin Naira
(NG@+@@@+@@@) 'hich 'as .*ll" s*-scri-e&(
?FFC3
8or t%e second time in t%e company9s %istory, t%e Ni+erian Stoc/ E2c%an+e
3erit .&ard &as received 'or t%e best presentation, 1uality and dept% o' t%e
annual report and accounts 'or t%e year #664
?FFB3
5echs# AG &i$es#e& i#s hl&ing .rm in Nigerian 5echs# Plc an& a# an e/#ra-
r&inar" General ;ee#ing hel& n AH Fe-r*ar" ?FFB+ #he sharehl&ers a!!r$e& #he
change . #he cm!an"%s name # MNigerian-German Chemicals PlcN(
?FF?+ ?FFG3
The a*#hriIe& share ca!i#al . #he cm!an" increase& # N?@@+@@@+@@@ #hr*gh A
s#ages (n D*l" H+ ?FF? 1 ;arch C+ ?FFG) an& #he !ai&-*! ca!i#al 'as increase& #
NH@+GAB+@@@ -" a -n*s iss*e . ne r&inar" share .r e$er" .*r r&inar" shares
alrea&" hel& (n D*l" H+ ?FF?) 1 righ#s iss*e in ?FFG(
?FFL3
T%e company9s turnover crosses t%e billion:naira mar/ 'or t%e 'irst time0
N;< entered strate+ic relations%ip &it% *ar/e:"avis =no& *'i>er <onsumer
)ealt%care? and introduced @enylin ran+es, .nusol A Sloan9s

NGC 6TORY 9 (cn#in*e&)
?FFF3
;r( A( 6hne2an a!!in#e& Chie. E/ec*#i$e O..icer(
T%e company commissions p%armaceutical oral li1uid line and produces li1uid medicines 'or t%e 'irst time at
t%e tta plant0
A@@@3 ur association &it% .ventis, t%e successor o' )oec%st +roup 'inally ended(
A@@?3 Cm!an"%s !ai&-*! ca!i#al increase& # NLG+OFH+@@@ .ll'ing a -n*s iss*e . ? ne' share .r e$er" G e/is#ing
shares(
A@@A3
NGC e/i#s agr $e#erinar" *n!r.i#a-le -*siness an& in&*s#rial chemicals(
N;< &as t%e proud recipient o' t%e *'i>er )ealt%care "ivision 4BB4 .+ent o' t%e !ear a&ard =E2port Re+ion?0
This a'ar& 'as in recgni#in . #he signi.ican# !rgress ma&e -" NGC in #he !r&*c#in an& &is#ri-*#in . a range .
P.iIer Cns*mer 5eal#hcare !r&*c#s incl*&ing )en"lin(
A@@H3
<ompany commissions its multi:million:naira bottled &ater plant0
July, sa& N;< e2pand into t%e bevera+e mar/et &it% t%e launc% o' its o&n brand o' bottled &ater, Spar&asser(
A@@C3 NGC cele-ra#es i#s C@#h anni$ersar"(
NGC !ar#ners E*nming Pharmace*#ical Cr!ra#in+ China 1 la*nches Ar#em (ar#emisinin an#i-malarial) in# #he
Nigerian mar2e#
A@@B3
<ompany9s turnover crosses t%e N4 billion =t&o billion naira? mar/ 'or t%e 'irst time0
NGC la*nches Gl*.rmin (an#i&ia-e#ic) # #he mar2e#
A@@G3 NGC la*nches ne' -ran&s3 Arc (an#imalarial)+ :im# (re.reshing .r*i# &rin2)+ Lin#n !ar2 ('ine) in# #he Nigerian
mar2e#(
A@@L3 N;< splits into 7 autonomous divisions, namely 3anup%arm, "istrip%arm, "istricon, @rand .ssets, and
S%ared Services

OUR )OARD

NGC Plc )OARD ;E;)ER6 7 PROFILE
C5AIR;AN
5R5 Alha8i 6heh* I&ris (CFR)
Alha8i I&ris is a seasne& a&minis#ra#r+ schlar an& a 'ell res!ec#e& #ra&i#inal r*ler( In #he
c*rse . his career+ he ser$e& in $ari*s !si#ins in #he ;inis#r" . Lcal G$ernmen#+ Paria
Lcal A*#hri#" c*ncil+ an& Ea&*na 6#a#e )ra&cas#ing Cr!ra#in(
5R5 is #he c*rren# Chairman . #he Ea&*na 6#a#e C*ncil . Chie.s an& Pr-Chancellr . #he
Uni$ersi#" . Technlg"+ ;inna an& Chancellr . #he Uni$ersi#" . Nigeria - Ns*2a( The Emir
si#s n #he )ar& . UAC an& UNIC Ins*rance PLC(
EQECUTI:E :ICE-C5AIR;AN 1 CEO
;r( A&e-"e 6hne2an
A la'"er -" !r.essin+ he is a ?FOG gra&*a#e .rm #he Uni$ersi#" . Rea&ing+ )er2shire+ Uni#e&
Eing&m( 5e als a##en&e& #he managemen# !rgram a# 5ar$ar& )*siness 6chl in ?FFO( Prir
# 8ining NGC in ?FFB as #he E/ec*#i$e Direc#r res!nsi-le .r ;a#erials ;anagemen#+
Lgis#ics 1 Im!r# Financing+ he ha& 'r2e& as In$es#men# O..icer 'i#h In#erna#inal Finance
Cr!ra#in (?FF@-?FFB)( 5e -ecame #he :ice-Chairman . #he )ar& n AO ;arch ?FFO an&
Chie. E/ec*#i$e O..icer . #he Cm!an" n AL A!ril ?FFF( 5e is als a Direc#r . se$eral #her
cm!anies+ incl*&ing Uni$erse Reins*rance Limi#e&+ :irgin Nigeria Limi#e&+ Cri#ical resc*e
In#erna#inal an& In#ers*rce 6 A Limi#e&
EQECUTI:E DIRECTOR+ CO;;ERCIAL
;r( ;a##he' Cha&Iim*ra
;a#he' Cha&Iim*ra 8ine& NGC in A@@G as Cmmercial Direc#r( 5e is a gra&*a#e . Uni$ersi#"
. Pim-a-'e+ 'here he -#aine& )-Tech ;anagemen# in ?FFH( 5e -ecame a Fell' ;em-er .
#he Asscia#in . Char#ere& Cer#i.ie& Acc*n#an#s (ACCA) (UE) in ?FFG an& als has an ;)A
.rm #he Uni$ersi#" . Pim-a-'e in A@@?(

NGC Plc )OARD ;E;)ER6 7 PROFILE6 cn#in*e&
NON-EQECUTI:E DIRECTOR6
;r( Emman*el N&i2'ere
;r( N&i2'ere hl&s an ;(6c( &egree in Fi-re 6cience an& Technlg" .rm #he Uni$ersi#" . Lee&s( 5e riginall"
8ine& #he .rmer 5echs# cm!an" in ?FLH an& ser$e& *n#il A@@? 'hen he re#ire& as hea& . #he In&*s#rial
Chemicals Di$isin( 5e -ecame an e/ec*#i$e &irec#r . NGC )ar& in ?FFF an& since re#iring has cn#in*e& #
ser$e #he cm!an" in a nn-e/ec*#i$e ca!aci#"(
;r( G-a&e )alg*n
;r( )alg*n is a Char#ere& Acc*n#an# 'h ser$e& .r $er AB "ears in se$eral !rminen# rganiIa#ins incl*&ing
Nigerian )re'eries an& UACN+ 'here he hel& #he !si#in . ;anaging Direc#r 4 G)O7;D6 -e.re re#iring .rm
ser$ice(
;r( Ol*seg*n A( Oshin'+
;r( Oshin' hl&s a )(6c )*siness A&minis#ra#in an& an ;6c in In&*s#rial Rela#ins 1 Persnnel ;anagemen#
.rm #he Uni$ersi#" . Lags+ Nigeria( 5e -ecame #he Direc#r General+ Nigeria Em!l"ers% Cns*l#a#i$e Asscia#in
since ?FFF( A .ell' . #he Char#ere& Ins#i#*#e . Persnnel ;anagemen#+ Nigeria+ he is n #he -ar& . se$eral
rganiIa#ins incl*&ing Nigeria 6cial Ins*rance Tr*s# F*n& (N6ITF)+ Nigeria La-*r A&$isr" C*ncil+ Na#inal
Pensin Cmmissin (PenCm)+ Na#inal Orien#a#in Agenc"+ an& #he Na#inal 5eal#h Ins*rance 6cheme( In
a&&i#in+ he is a mem-er . #he g$erning -ar& . In#erna#inal La-*r OrganiIa#in+ In#erna#inal OrganiIa#in .
Em!l"ers an& Pan-A.rican Em!l"ers Fe&era#in(
;r( Tm Lin&sa" ()ri#ish)
Tm Lin&sa" has $er C@ "ears e/!erience in #he !harmace*#ical in&*s#r"( 5e has hel& senir !si#ins in $erseas
!era#ins . se$eral lea&ing m*l#ina#inal cm!anies+ incl*&ing 5echs# ;arin R*ssel( In ?FFB he le.# #he
5echs# Gr*! # se# *! Tra&eLin2 In#erna#inal L#& # !r$i&e 5echs# 'i#h *#s*rce& mar2e#ing an& &is#ri-*#in
in A.rica an& #he Cari--ean( This has e$l$e& # !r$i&ing !harmace*#ical cm!anies 'i#h managemen# an&
lgis#ics ser$ices+ incl*&ing !rc*remen#+ #echnlg" #rans.er+ recr*i#men# an& mar2e#ing s*!!r#( As NGC%s
$erseas &irec#r in resi&ence in Ln&n+ Tra&eLin2 In#erna#inal L#& ser$es as NGC%s $erseas liaisn ..ice(
;r( 6amsn Ose'a
A !harmacis# -" !r.essin+ ;r( 6amsn Y( Ose'a 8ine& #he Cm!an" in ?FOA( 5e -ecame #he E/ec*#i$e Direc#r
in charge . Technical O!era#ins n AO ;arch ?FFO an& 'as res!nsi-le .r #he Pharmace*#ical -*siness *n#il
Dan*ar" A@@O 'hen he re#ire& .rm ac#i$e ser$ice a.#er AG "ears . meri#ri*s ser$ice( 5e has -een re#aine& n #he
-ar& . #he cm!an" in a nn-e/ec*#i$e ca!aci#"(

NGC-O<NED P5AR;A )RAND6

NGC O<NED P5AR;A PRODUCT6 PORTFOLIO

ANALGE6IC 7 ANTIPYRETIC
4
NGC-$alginR (Ace#amin!hen) Ta-s 1 In8ec#in+
DagaR (Parace#aml) Ta-s 1 6"r*!

ANALGE6IC 7 ANTIINFLA;;ATORY
4
Ta-alnR (I-*!r.en) Ta-le#s

ANTIDIA)ETIC6
4
GlanilR (Gli-enclami&e) #a-s 1 Gl*.rminR
(;e#.rmin) Ta-s

ANTI5EL;INT5IC
4
An#elminR (P"ran#el Pama#e) Ta-s

NGC O<NED P5AR;A PRODUCT6 PORTFOLIO

ORAL ANTI)IOTIC6
4
Tra.l/R (O.l/acin)+ Ci!r$alR (Ci!r.l/acin) 1
Per.l$alR (O.l/acin) Ta-le#s

ORAL DIURETIC6
4
NGC-Di*re/R (Fr*semi&e) Ta-le#s

ORAL ANTI-ULCER
4
Ulce!ralR (Rani#i&ine) Ta-le#s

;UCOLYTIC
4
)rnchl"#eR ()rmhe/ine 5Cl) Eli/ir

NGC-O<NED P5AR;A PRODUCT6 PORTFOLIO

COUG5 1 COLD
4
C.eeIeR (I!ecac*ana !l*s) Nn-&r's"
6"r*!

ORAL ANTI-6PA6;ODIC
4
Cli!anR (5"scine )*#"l )rmi&e) Ta-le#s 1
Eli/ir

ORAL ANTI-;ALARIAL
4
Fas#a0*ineR (Chlr0*ine)

NGC-O<NED FA6T ;O:ING CON6U;ER GOOD
PORTFOLIO

)OTTLED TA)LE <ATER RANGE

4
6!ar'asserR 6#ill
4
6!ar'asserR 6!ar2ling
4
6!ar'asserR A!!le Fla$*re&
4
6!ar'asserR Lime 1 Lemn Fla$*re&

FOREIGN PRINCIPAL6%
)RAND PORTFOLIO 4
P5AR;A

NGC PARTNER6% PRODUCT6 PORTFOLIO

Dhnsn 1 Dhnsn Pr&*c#s% Pr#.li

4
)en"linR Range (C*gh 1 Cl&)
4
6lans% Linimen#R (An#i-in.lamma#r" 4
s!rains+ &islca#ins)
4
A-i&ecR Dr!s (Chil&ren ;*l#i$i#amins)
4
An*slR 6*!!si#r" (An#i-hemrrhi& 7
As#ringen#)

NGC PARTNER6% PRODUCT6 PORTFOLIO cn#in*e&

6l$a" Pharma (France)

4
D*!has#nR #a-le#s (5rmnal 7
G"naeclg")
4
D*s!a#alinR (An#is!asm&ic)
4
D*!halacR (An#i-&iarrhea)

NGC PARTNER6% PRODUCT6 PORTFOLIO cn#in*e&

E*nming Pharmace*#ical Cr!ra#in

(China)
4
Ar#emR (An#imalarial) Ta-le#s 1 In8ec#in
4
ArcR (An#imalarial) #a-le#s

FOREIGN PRINCIPAL6 )RAND
PORTFOLIO 4 FA6T ;O:ING
CON6U;ER GOOD6

NGC CON6U;ER PRODUCT6 PORTFOLIO

CAR)ONATED FRUIT DRINE6

4 :im#R 6!ar2ling+ :im#R Cr&ial 1 :im#R Li#e (Un&er
Pr&*c#in 1 6ales 1 Dis#ri-*#rshi! Agreemen# 'i#h Nichls
Plc+ UE)

)LEAC5 7 6TERILIPER
4 ParIneR )leach 1 Per.*me& )leach (*n&er Pr&*c#in 1
6ales 1 Dis#ri-*#rshi! Agreemen# 'i#h De"es+ UE)

<INE6
4 Ca-erne# 6a*$ignn+ ;erl#+ Cha&nna"+ 6a*$ign )lan2
(*n&er 6ales 1 Dis#ri-*#rshi! Agreemen# 'i#h Lin#n Par2
<ines+ 6*#h A.rica)
4 R*ssians )ear :&2a+ 5!er 6chna!!s+ T' Ee"s <his2e"+
6#re##n%s Gin (*n&er 6ales 1 Dis#ri-*#rshi! Agreemen# 'i#h
E&'ar& 6niels Plc+ 6*#h A.rica)